Institut Curie
Founded by Marie Curie; a leader in breast cancer, radiotherapy, and proton therapy.
Comprehensive cancer centre and research institute; leadership in TNBC biology, uveal melanoma, paediatric oncology, and the Orsay proton centre.
- Breast cancer
- Proton therapy
- Uveal melanoma
Led SHIVA, the first randomised trial of genomics-matched therapy, and heads Institut Curie's early trials unit.
Eliane Piaggio is an immunologist studying regulatory T cells and immune profiling to guide immunotherapy.
Led PADA-1, the first trial to switch endocrine therapy on a rising ESR1 mutation in blood.
Olivier Delattre discovered the EWS-FLI1 fusion that defines Ewing sarcoma.
Directs the translational research department that developed models and targets for uveal melanoma.
Steven Le Gouill is a lymphoma specialist who leads the Institut Curie hospitals.
Pages like this
not linked directly; found by shared links- InstitutionGustave Roussy
Shares Fondation ARC pour la recherche sur le cancer, Institut Pasteur, Haute Autorité de Santé, Institut National du Cancer.
- InstitutionLigue nationale contre le cancer
Shares Fondation ARC pour la recherche sur le cancer, UNICANCER.
- InstitutionCentre Antoine Lacassagne
Shares UNICANCER, Proton therapy, Melanoma.
- InstitutionInstitut Bergonié
Shares Institut National du Cancer, UNICANCER.
- TermImmune exclusion
Shares What actually holds T cells at the tumour border?, Tumour microenvironment (TME).
- PathwayPD-1 / PD-L1 immune checkpoint & T-cell activation
Shares Eliane Piaggio, What actually holds T cells at the tumour border?, Tumour microenvironment (TME), Triple-negative breast cancer (TNBC).
- InstitutionInstitut Paoli-Calmettes
- InstitutionIUCT Oncopole – Institut Universitaire du Cancer de Toulouse